News Focus
News Focus
Post# of 257253
Next 10
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

Re: DewDiligence post# 161403

Thursday, 05/23/2013 5:13:29 PM

Thursday, May 23, 2013 5:13:29 PM

Post# of 257253
MRK drops Preladenant program in Parkinson’s disease after phase-3 failure:

http://finance.yahoo.com/news/merck-provides-phase-iii-clinical-210000918.html

Fortunately, this was not one of the big-4 opportunities in MRK’s pipeline, which are enumerated in #msg-88122327.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now